Back to Agenda
Site Selection and Feasibility Symposium
Session Chair(s)
Ira Charles Spector, PHD, MBA
Chief Executive Officer, SFA Therapeutics, Inc., United States
Predicting Clinical Research Site Performance
Learning Objective : Discuss how to identify potential sites that are more likely to enroll and retain patients, using predictive performance metrics; Describe how to change the site selection process to utilize these contemporary approaches; Explain what sponsors can do to help improve site performance.
Speaker(s)
Ira Charles Spector, PHD, MBA
Chief Executive Officer, SFA Therapeutics, Inc., United States
Predicting Clinical Research Site Performance
Elisabeth Otto, MA
Product Manager, CTOS, QuintilesIMS, United States
Mining the Mother Lode: Harnessing the Right Data and Metrics to Find the Best Sites for Your Study
Rebecca Little
Associate Director, Business Development, Rx Trials, Inc, United States
Using a Data-Driven Approach at the Site Level During the Feasibility Process to Help Ensure a More Accurate Trial Outcome
Daniel M Ulrey, MBA
President and Chief Executive Officer, Midwest Clinical Support, Inc., United States
Site Perspective
Have an account?